CXCL12 and myeloid sarcoma: The median (IQR) CXCL12 serum protein concentrations in the control and MS groups were 36.6 (6.8) and 35.4 (10.3), respectively, with a not statistically significant tendency for a higher CXCL12 concentration in the control group (p = 0.166).